2p4j: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2p4j.gif|left|200px]]
{{Seed}}
[[Image:2p4j.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2p4j|  PDB=2p4j  |  SCENE=  }}  
{{STRUCTURE_2p4j|  PDB=2p4j  |  SCENE=  }}  


'''Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3'''
===Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3===




==Overview==
<!--  
Structure-based design and synthesis of a number of potent and selective memapsin 2 inhibitors are described. These inhibitors were designed based upon the X-ray structure of memapsin 2-bound inhibitor 3 that incorporates methylsulfonyl alanine as the P2-ligand and a substituted pyrazole as the P3-ligand. Of particular importance, we examined the ability of the substituted isophthalic acid amide derivative to mimic the key interactions in the S2-S3 regions of the enzyme active sites of 3-bound memapsin 2. We investigated various substituted phenylethyl, alpha-methylbenzyl, and oxazolylmethyl groups as the P3-ligands. A number of inhibitors exhibited very potent inhibitory activity against mempasin 2 and good selectivity against memapsin 1. Inhibitor 5d has shown low nanomolar enzyme inhibitory potency (Ki=1.1 nM) and very good cellular inhibitory activity (IC50=39 nM). Furthermore, in a preliminary study, inhibitor 5d has shown 30% reduction of Abeta40 production in transgenic mice after a single intraperitoneal administration (8 mg/kg). A protein-ligand X-ray crystal structure of 5d-bound memapsin 2 provided vital molecular insight that can serve as an important guide to further design of novel inhibitors.
The line below this paragraph, {{ABSTRACT_PUBMED_17432843}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17432843 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17432843}}


==About this Structure==
==About this Structure==
Line 35: Line 39:
[[Category: Memapsin]]
[[Category: Memapsin]]
[[Category: Structure based drug design]]
[[Category: Structure based drug design]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 12:20:40 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 19:25:56 2008''